07/28/2026

Meet the Recipients of the Inaugural MSHO Research Grant Awards!

The Michigan Society of Hematology and Oncology is pleased to announce the recipients of the 2026 MSHO Research Grant Awards.

MSHO launched this research initiative with the belief that transformative cancer care begins with research that is inclusive, community-driven, and responsive to the real-world challenges faced by patients and providers. Through this call for proposals, MSHO sought to support projects that identify barriers to care and clinical trial participation and develop actionable solutions to improve outcomes for patients across Michigan.

Their projects address important barriers to cancer care and clinical trial participation, reflecting MSHO's commitment to supporting research that leads to better outcomes and more equitable access to care for patients across Michigan.

N. Lynn Henry, MD, PhD
Rogel Cancer Center | University of Michigan
Advancing Equity and Representation in Clinical Trials through Community-Engaged, Participatory Approaches

Shruti Jolly, MD, MBA
Michigan Medicine | University of Michigan
Assessing and Enhancing Next-Generation Clinical Trial Readiness Among Breast and Lung Cancer Patients Within the Michigan Radiation Oncology Quality Consortium (MROQC),

MSHO is proud to support these outstanding researchers and looks forward to following the progress and impact of their work. We thank all applicants for their submissions and their continued commitment to advancing oncology and hematology research.

Congratulations to our 2026 grant recipients!